Advanced search
1 file | 37.23 KB Add to list

PET as a predictor of metabolic response to antiangiogenic therapy in metastatic colorectal cancer (mCRC)

Nancy Van Damme (UGent) , SYLVIE DE BRUYNE (UGent) , Liesbeth Ferdinande (UGent) , Wim Ceelen (UGent) , Jeroen Mertens (UGent) , Christophe Van De Wiele (UGent) , Stéphanie Laurent (UGent) , Peter Smeets (UGent) , Karen Geboes (UGent) and Marc Peeters (UGent)
(2011) ANNALS OF ONCOLOGY. 22(suppl. 5). p.V92-V92
Author
Organization

Downloads

  • Van Damme et al. WCGIC 2011.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 37.23 KB

Citation

Please use this url to cite or link to this publication:

MLA
Van Damme, Nancy et al. “PET as a Predictor of Metabolic Response to Antiangiogenic Therapy in Metastatic Colorectal Cancer (mCRC).” Annals of Oncology. Vol. 22. 2011. V92–V92. Print.
APA
Van Damme, Nancy, DE BRUYNE, S., Ferdinande, L., Ceelen, W., Mertens, J., Van De Wiele, C., Laurent, S., et al. (2011). PET as a predictor of metabolic response to antiangiogenic therapy in metastatic colorectal cancer (mCRC). ANNALS OF ONCOLOGY (Vol. 22, pp. V92–V92). Presented at the 13th World congress of Gastrointestinal Cancer.
Chicago author-date
Van Damme, Nancy, SYLVIE DE BRUYNE, Liesbeth Ferdinande, Wim Ceelen, Jeroen Mertens, Christophe Van De Wiele, Stéphanie Laurent, Peter Smeets, Karen Geboes, and Marc Peeters. 2011. “PET as a Predictor of Metabolic Response to Antiangiogenic Therapy in Metastatic Colorectal Cancer (mCRC).” In Annals of Oncology, 22:V92–V92.
Chicago author-date (all authors)
Van Damme, Nancy, SYLVIE DE BRUYNE, Liesbeth Ferdinande, Wim Ceelen, Jeroen Mertens, Christophe Van De Wiele, Stéphanie Laurent, Peter Smeets, Karen Geboes, and Marc Peeters. 2011. “PET as a Predictor of Metabolic Response to Antiangiogenic Therapy in Metastatic Colorectal Cancer (mCRC).” In Annals of Oncology, 22:V92–V92.
Vancouver
1.
Van Damme N, DE BRUYNE S, Ferdinande L, Ceelen W, Mertens J, Van De Wiele C, et al. PET as a predictor of metabolic response to antiangiogenic therapy in metastatic colorectal cancer (mCRC). ANNALS OF ONCOLOGY. 2011. p. V92–V92.
IEEE
[1]
N. Van Damme et al., “PET as a predictor of metabolic response to antiangiogenic therapy in metastatic colorectal cancer (mCRC),” in ANNALS OF ONCOLOGY, Barcelona, Spain, 2011, vol. 22, no. suppl. 5, pp. V92–V92.
@inproceedings{2043831,
  articleno    = {abstract P-0257},
  author       = {Van Damme, Nancy and DE BRUYNE, SYLVIE and Ferdinande, Liesbeth and Ceelen, Wim and Mertens, Jeroen and Van De Wiele, Christophe and Laurent, Stéphanie and Smeets, Peter and Geboes, Karen and Peeters, Marc},
  booktitle    = {ANNALS OF ONCOLOGY},
  issn         = {0923-7534},
  language     = {eng},
  location     = {Barcelona, Spain},
  number       = {suppl. 5},
  pages        = {abstract P-0257:V92--abstract P-0257:V92},
  title        = {PET as a predictor of metabolic response to antiangiogenic therapy in metastatic colorectal cancer (mCRC)},
  volume       = {22},
  year         = {2011},
}

Web of Science
Times cited: